Neal Copeland and colleagues use a transposon mutagenesis screen to identify drivers of hepatocellular carcinoma in a mouse model of chronic hepatitis B infection.
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
![]() ![]() |
BigField GEG Tech's curator insight,
December 9, 2013 4:25 AM
An original use of a transposon to better understand the hepatocarcinoma mechanisms.
|
Smart use of transposon to better characterize hepatocellular carcinoma.
http://geg-tech.com